Robotic vs. VATS surgery for early lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study compares two types of minimally invasive surgery—robotic-assisted (da Vinci) and VATS—for people with early-stage non-small cell lung cancer. The goal is to see which approach might work better and help patients recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have early-stage non-small cell lung cancer, specifically stage IA1 or IA2.
- You will be having either robotic-assisted surgery (da Vinci) or VATS (video-assisted thoracoscopic surgery).
- You need to be 18 years or older.
- You must be willing to follow the study rules, including attending follow-up visits, and sign a consent form.
- You cannot have cancer that has spread to other organs (metastatic) or be having an emergency surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two minimally invasive surgeries for early-stage non-small cell lung cancer: robotic-assisted (RATS) versus video-assisted (VATS). It aims to see which approach is better for removing a lobe or part of a lobe, focusing on recovery and safety.
This study compares an image-guided version of a minimally invasive lung surgery to the standard approach for removing small lung nodules. It may help doctors improve planning and targeting of the nodule during surgery.
This trial compares two types of robot-assisted lung surgery for early-stage non-small cell lung cancer. One method uses a fully robotic setup, and the other involves the surgeon helping with part of the procedure. The goal is to see which approach works better for patients.
This trial tests whether robotic-assisted surgery for lung cancer is safe and effective in elderly patients. It may be a good option if you are older and able to undergo surgery.
This trial studies a new surgical robot that uses only one small opening in the chest to remove a lung segment or lobe. It aims to see if the robot is safe and effective for patients who need this type of surgery.
This trial studies whether a minimally invasive lung surgery (VATS) works as well as the more open approach (thoracotomy) for certain early-stage lung cancers. It may help patients and surgeons choose the best operation method for tumors that can be fully removed.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.